These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2116584)

  • 1. Measurement of cost-effectiveness of drug therapy: a review of the treatment of hypertension.
    Moulds RF
    Med J Aust; 1990 Aug; 153(S1):S4-6. PubMed ID: 2116584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of antihypertensive drug treatment on the incidence of stroke and of coronary heart disease.
    MacMahon S
    Clin Exp Hypertens A; 1989; 11(5-6):807-23. PubMed ID: 2676257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive drug treatment: the potential, expected and observed effects on vascular disease.
    MacMahon S
    J Hypertens Suppl; 1990 Dec; 8(7):S239-44. PubMed ID: 2151335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Do antihypertensive agents change the incidence of cardiovascular complications of hypertension?].
    Himbert D; Paillole C; Dahan M; Steg PG; Laperche T; Gourgon R
    Ann Cardiol Angeiol (Paris); 1991 Dec; 40(10):607-12. PubMed ID: 1685878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of antihypertensive drug treatment on the incidence of cardiovascular morbidity and mortality in mild arterial hypertension].
    Tomov I
    Vutr Boles; 1985; 24(6):39-47. PubMed ID: 3913145
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complication and prognosis in essential hypertension].
    Hiwada K; Imamura Y
    Nihon Rinsho; 1992 May; 50 Suppl():238-45. PubMed ID: 1387423
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertension: a new perspective in therapy and metabolic effect. Part I.
    Medina Ruiz A
    Bol Asoc Med P R; 1991 Sep; 83(9):399-401. PubMed ID: 1807274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension as a risk factor for cardiac events--epidemiologic results of long-term studies.
    Kannel WB
    J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S27-37. PubMed ID: 7692148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arterial hypertension and cardiovascular risk. Epidemiological studies, trials and therapeutic implications].
    Iannetti M; Vallebona A; Caponnetto S
    Minerva Cardioangiol; 1991 Oct; 39(10):367-74. PubMed ID: 1803282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population.
    Antikainen R; Jousilahti P; Tuomilehto J
    J Hypertens; 1998 May; 16(5):577-83. PubMed ID: 9797168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients.
    Milne RJ; Vander Hoorn S; Jackson RT
    Pharmacoeconomics; 1997 Sep; 12(3):384-408. PubMed ID: 10170463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease.
    Collins R; MacMahon S
    Br Med Bull; 1994 Apr; 50(2):272-98. PubMed ID: 8205459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and differential antihypertensive therapies.
    Os I
    Acta Med Austriaca; 1995; 22(3):45-7. PubMed ID: 8571750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing cardiovascular disease in hypertension: effects of lowering blood pressure and cholesterol.
    Green R; Kwok S; Durrington PN
    QJM; 2002 Dec; 95(12):821-6. PubMed ID: 12454325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study.
    Gu D; He J; Coxson PG; Rasmussen PW; Huang C; Thanataveerat A; Tzong KY; Xiong J; Wang M; Zhao D; Goldman L; Moran AE
    PLoS Med; 2015 Aug; 12(8):e1001860. PubMed ID: 26241895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk predictors, risk indicators, and benefit factors in hypertension.
    Dollery CT
    Am J Med; 1987 Jan; 82(1A):2-8. PubMed ID: 3799698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.
    He J; Whelton PK
    J Hypertens Suppl; 1999 Jun; 17(2):S7-13. PubMed ID: 10465061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the pharmacological treatment of mild to moderate hypertension cost effective in stroke prevention?
    Malcolm LA; Kawachi I; Jackson R; Bonita R
    N Z Med J; 1988 Apr; 101(843):167-71. PubMed ID: 3128747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating hypertension--effect of treatment and cost-effectiveness in respect to later cardiovascular diseases.
    Hedner T
    Scand Cardiovasc J Suppl; 1998; 47():31-5. PubMed ID: 9540131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.